Part of the Pemphigus & Autoimmune Blistering Disease Knowledge Library
Everyone treated the blisters. The itch that arrived before them — the earliest warning the disease gave — was the first thing to settle.
| Age at first consultation | 78 |
|---|---|
| Duration before EliteAyurveda | 1 year |
| Disease pattern at presentation | Fluctuating — controlled but never stable |
| Presenting picture | Tense blisters on arms, legs and abdomen; itch preceding each flare; sleep broken by itching; poor appetite |
| Prior treatment | Long-term oral steroids with repeated dose escalation, under dermatology care |
| Dominant drivers identified | Immune · Gut |
A year of bullous pemphigoid, already under regular dermatology care, and still not settling. The record's own word for it was fluctuating — controlled at times, but never truly stable.
The skin showed large, tense, fluid-filled blisters on the arms, legs and abdomen, with redness, a burning sensation, and slow healing that left pigmentation behind after each one. The blisters were tense rather than flaccid because pemphigoid splits the skin deep, beneath the epidermis, so the roof is thick and the blister survives — the feature that separates it from pemphigus.
But the detail that mattered most was the itch: severe, constant, and arriving before new blisters appeared. Alongside it, long-term oral steroids with repeated dose escalation, low stamina, poor appetite and heaviness after meals, and sleep broken night after night by scratching.
The itch that comes before the blister is the classic, most-missed feature of bullous pemphigoid. At the onset of the disease it can precede blistering by months, which is why so many people are treated for eczema, or even scabies, long before anyone reaches a biopsy.
The steroid escalation is the other tell. A dose that goes up, comes down a little, and goes up again is a disease being contained rather than quietened — and at seventy-eight, every increment of steroid is bone, blood sugar, infection risk, and skin that thins and tears. Nothing in that cycle was anyone's mistake. The dermatologist was doing exactly what the disease demanded. It was simply a cycle with a direction, and the direction was not good.
The plan was built after assessing digestion, the pattern of immune disturbance, the extent of skin involvement, and the full medication history — with the emphasis on gradual internal correction rather than sudden withdrawal, introduced step by step.
That maps onto the EPOH phase sequence: lowering the inflammatory load first, then internal healing and gut repair, then clearance, with home-applied external care for the skin throughout and a low-intensity maintenance set afterwards.
One boundary matters here, and it is not a small one. We do not taper steroids. Every decision about prednisolone belongs to the dermatologist who prescribed it — sudden withdrawal risks adrenal insufficiency and a rebound flare, and a rebound flare in a blistering disease is not a minor event. What internal work can do is make the surface a dermatologist attempts a taper on a quieter one.
On the skin: no new blister formation, existing blisters healing without rupturing, and itching, redness and burning all reduced. Skin strength and tolerance improved.
Internally: appetite returned, digestion became lighter and regular, energy stabilised, and sleep was no longer broken by itch — which, after a year of nights governed by scratching, was not a small line in the record.
On medication: the steroid dose was reduced gradually, under the dermatologist's supervision, with no rebound flare during the taper. By the end of the recorded episode the patient was clinically stable, with no active blistering.
The shape of this case — the itch before the blister, the dose that keeps climbing, the year of being controlled without ever being stable — is exactly the shape this protocol is built for, and exactly the shape most often left alone until it worsens.
It remains supportive care alongside a dermatologist, never instead of one. Bullous pemphigoid can relapse if the internal picture is disturbed again, which is the whole reason a maintenance phase exists. The aim is a quieter disease under less load — sustained remission, honestly described, not a cure we would never claim.
Medical disclaimer. This is one patient's documented course of treatment. Individual response varies with disease duration, degree of involvement and remaining biological repair capacity — not every patient reaches the same outcome. Nothing here is a substitute for personalised medical advice, and no medication should be started, stopped or altered without consulting your treating physician.
